Chemoinformaics analysis of Pentadecanoic acid, 14-methyl-, methyl ester
| Molecular Weight | 270.457 | nRot | 13 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 1 |
| Exact Molecular Weight | 270.256 | nRing | 0 |
| Solubility: LogS | -6.594 | nHRing | 0 |
| Solubility: LogP | 6.96 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 52.665 |
| nHD | 0 | BPOL | 36.713 |
| QED | 0.326 |
| Synth | 1.823 |
| Natural Product Likeliness | 0.409 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.084 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.656 |
| MDCK | 0.0000154 |
| BBB | 0.362 |
| PPB | 0.971388 |
| VDSS | 1.571 |
| FU | 0.0182457 |
| CYP1A2-inh | 0.467 |
| CYP1A2-sub | 0.207 |
| CYP2c19-inh | 0.508 |
| CYP2c19-sub | 0.227 |
| CYP2c9-inh | 0.362 |
| CYP2c9-sub | 0.964 |
| CYP2d6-inh | 0.043 |
| CYP2d6-sub | 0.038 |
| CYP3a4-inh | 0.356 |
| CYP3a4-sub | 0.095 |
| CL | 5.61 |
| T12 | 0.262 |
| hERG | 0.12 |
| Ames | 0.005 |
| ROA | 0.026 |
| SkinSen | 0.951 |
| Carcinogencity | 0.068 |
| EI | 0.965 |
| Respiratory | 0.88 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.68099 |